Applied Genetic Technologies Corporation Appoints David R. Guyer, MD, And Ivana Magovcevic-Liebisch, Phd, JD, To Its Board Of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GAINESVILLE, Fla., June 30, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced that it has appointed David R. Guyer, MD, and Ivana Magovcevic-Liebisch, PhD, JD, to the company's Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

Back to news